Latest International Collaborations News

Strategic Elements Ltd has received $1.2 million in applications under its Share Purchase Plan, surpassing its initial $1 million target and raising the cap to $2.5 million. The extra funds will accelerate development of its moisture-powered Energy Ink™ and operational intelligence platform EdgeiQ™.

NeuRizer Ltd advanced its urea project with Reliance Industries payments and environmental submissions, despite ongoing ASX trading suspension and overdue financial reports.

Noxopharm’s SOF-16 active ingredient demonstrated potent anti-inflammatory activity in patient-derived samples of systemic lupus erythematosus and rheumatoid arthritis, advancing its Sofra™ platform beyond topical applications.

Prairie Lithium has secured a binding offtake agreement with Hydro Lithium for 100% of its Phase 1 lithium carbonate production, alongside a strategic AU$10 million equipment collaboration. This deal marks a significant milestone for Prairie’s Saskatchewan project, targeting first production in late 2026.

Cauldron Energy Limited has clarified that its recent share price jump is driven by easing geopolitical tensions and a buoyant uranium market, with no undisclosed material information influencing trading.

Resolute Mining and Guinea’s state-owned Nimba Mining Company have signed a landmark MoU to jointly explore and potentially develop gold projects, marking a significant step in Guinea’s mineral diversification.

PPK Group Limited has reported a remarkable turnaround with a $10.5 million profit for H1 2026, driven by a significant non-cash gain from its Li-S Energy investment and strategic portfolio adjustments.

Carnegie Clean Energy reported a $1.7 million loss for the half-year ending December 2025, while pushing forward with key wave energy projects and securing $2.1 million in fresh capital.

Tivan Limited has submitted a confidential draft Feasibility Study for its Speewah Fluorite Project to key partners, marking a significant step towards project finalisation and potential production.

Worley Limited has been awarded a reimbursable EPC contract for Phase 2 of the CP2 Project, reinforcing its role in a strategically vital global energy infrastructure initiative.

Neurizon Therapeutics has secured FDA clearance for its lead drug candidate NUZ-001 to enter the HEALEY ALS Platform Trial, marking a key regulatory milestone and setting the stage for patient enrollment in early 2026.

Strategic Elements Ltd has marked a key milestone by successfully fabricating Energy Ink™ prototype cells in a commercial setting, while expanding its artificial intelligence ventures and maintaining a robust financial position.